MOTS-c is a mitochondrial-derived peptide. Sequence identity, species context and experimental controls matter because mechanistic results depend on the model and endpoint.
What procurement and laboratory teams should review
Confirm human sequence and terminal chemistry
Use a justified scrambled or vehicle control
Record cell state, nutrient conditions and timing
Avoid translating preclinical findings into human-use claims
Define the molecular form before comparing offers
Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.
- Record sequence, termini and every modification explicitly.
- State the requested salt or counterion form.
- Treat solubility and stability as material- and condition-specific.
Questions to resolve before quotation or release
- Is the sequence explicitly human?
- What controls are included?
- Does evidence match the study material?
Identify species sequence and control strategy in the RFQ.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.